Abstract
Objective:We estimated premature mortality and identified causes of death and associated factors in people with active convulsive epilepsy (ACE) in rural Kenya.Methods:In this prospective population-based study, people with ACE were identified in a cross-sectional survey and followed up regularly for 3 years, during which information on deaths and associated factors was collected. We used a validated verbal autopsy tool to establish putative causes of death. Age-specific rate ratios and standardized mortality ratios were estimated. Poisson regression was used to identify mortality risk factors.Results:There were 61 deaths among 754 people with ACE, yielding a rate of 33.3/1,000 persons/year. Overall standardized mortality ratio was 6.5. Mortality was higher across all ACE age groups. Nonadherence to antiepileptic drugs (adjusted rate ratio [aRR] 3.37), cognitive impairment (aRR 4.55), and age (50+ years) (rate ratio 4.56) were risk factors for premature mortality. Most deaths (56%) were directly related to epilepsy, with prolonged seizures/possible status epilepticus (38%) most frequently associated with death; some of these may have been due to sudden unexpected death in epilepsy (SUDEP). Possible SUDEP was the likely cause in another 7%.Conclusion:Mortality in people with ACE was more than 6-fold greater than expected. This may be reduced by improving treatment adherence and prompt management of prolonged seizures and supporting those with cognitive impairment.
Highlights
Mortality in people with active convulsive epilepsy (ACE) was more than 6-fold greater than expected
Epilepsy is one of the most common noncommunicable neurologic conditions in the world, estimated to affect approximately 70 million people, with up to 90% living in low- and middleincome countries (LMICs).[1]
It is associated with premature mortality, 1.3–9.3 times that of the background population in high-income countries (HICs) and much higher in institutionalized people and those with cerebral malformations.[2,3]
Summary
In this prospective population-based study, people with ACE were identified in a crosssectional survey and followed up regularly for 3 years, during which information on deaths and associated factors was collected. Age-specific rate ratios and standardized mortality ratios were estimated. Poisson regression was used to identify mortality risk factors. The study setting and population characteristics have been described previously.[17,18,19] Briefly, the study was within the Kilifi Health and Demographic Surveillance System (KHDSS) Kemri-wellcome.org/khdss/) in the Kilifi District of Kenya. In 2008 there were 233,800 people in the study area.[20] Households were mapped using global positioning system, and maps were used to locate and follow up participants. Field personnel conduct re-enumeration and vital status updates of the population register 3 times per year
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have